AS-1896596

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAS-1896596
Drug Alias Nameimmunosuppressant (Astellas)FR-276457AS-1896596
ClassificationSmall molecules
Mechanisms of ActionImmunosuppressantsHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsRejection of organ transplantationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A